The FDA panel will review seven peptides and decide if they should be added to a list of substances that can be safely produced by compounding pharmacies.
\n\n
The FDA panel will review seven peptides and decide if they should be added to a list of substances that can be safely produced by compounding pharmacies.
The new Gold+ initiative would allow private contractors to handle passenger screening at three airports while the TSA retains federal oversight.
In today’s edition, we examine how the escalating Iran war is playing out in the oil markets and the halls of the Capitol. Plus, Scott Wong and Matt Dixon have…